探索在低收入和中等收入国家的医生减少处方做法的看法:一项混合方法的研究。

IF 3.3 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Anjan Khadka, Sammodavardhana Kaundinnyayana, Kumar Roka, Arjun Poudel, Shakti Shrestha
{"title":"探索在低收入和中等收入国家的医生减少处方做法的看法:一项混合方法的研究。","authors":"Anjan Khadka,&nbsp;Sammodavardhana Kaundinnyayana,&nbsp;Kumar Roka,&nbsp;Arjun Poudel,&nbsp;Shakti Shrestha","doi":"10.1111/bcpt.70121","DOIUrl":null,"url":null,"abstract":"<p>With the increasing prevalence of potentially inappropriate medications in low- and middle-income countries (LMICs) like Nepal, the role of deprescribing is ever important. However, evidence on how Nepalese doctors perceive deprescribing in their practice is lacking. A sequential explanatory mixed-method study was conducted among 115 doctors at a tertiary-level teaching hospital in central Nepal using a structured questionnaire. Quantitative data from Likert-scale items were analysed descriptively, while thematically analysing open-ended responses. Only 45 doctors (39.1%) had heard of deprescribing, and 77.8% reported practising it. Most doctors (80%) understood the rationale behind each prescription, and 94.3% agreed on ensuring patient comprehension of prescribed medicines. Only 52.4% routinely involved patients in deprescribing decisions, and 31.4% acknowledged prescribing ‘too many drugs’ at times. Qualitative analysis identified three deprescribing-related themes: (1) general understanding: deprescribing viewed as a planned, systematic process to optimize treatment, minimize polypharmacy, reduce costs, and improve safety; (2) Enablers: patient factors, treatment considerations, medication issues, disease process, prescriber competencies and institutional support; (3) barriers: patient resistance, prescribing inertia, knowledge gaps, coordination issues, time constraints, cost and pharmaceutical influences. Doctors demonstrated a moderate understanding of deprescribing but faced several contextual challenges, highlighting the need for targeted education, institutional policies and deprescribing frameworks in LMICs.</p>","PeriodicalId":8733,"journal":{"name":"Basic & Clinical Pharmacology & Toxicology","volume":"137 5","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12497502/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exploration of Perceptions of Deprescribing Practices Among Doctors in a Low- and Middle-Income Country: A Mixed-Methods Study\",\"authors\":\"Anjan Khadka,&nbsp;Sammodavardhana Kaundinnyayana,&nbsp;Kumar Roka,&nbsp;Arjun Poudel,&nbsp;Shakti Shrestha\",\"doi\":\"10.1111/bcpt.70121\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>With the increasing prevalence of potentially inappropriate medications in low- and middle-income countries (LMICs) like Nepal, the role of deprescribing is ever important. However, evidence on how Nepalese doctors perceive deprescribing in their practice is lacking. A sequential explanatory mixed-method study was conducted among 115 doctors at a tertiary-level teaching hospital in central Nepal using a structured questionnaire. Quantitative data from Likert-scale items were analysed descriptively, while thematically analysing open-ended responses. Only 45 doctors (39.1%) had heard of deprescribing, and 77.8% reported practising it. Most doctors (80%) understood the rationale behind each prescription, and 94.3% agreed on ensuring patient comprehension of prescribed medicines. Only 52.4% routinely involved patients in deprescribing decisions, and 31.4% acknowledged prescribing ‘too many drugs’ at times. Qualitative analysis identified three deprescribing-related themes: (1) general understanding: deprescribing viewed as a planned, systematic process to optimize treatment, minimize polypharmacy, reduce costs, and improve safety; (2) Enablers: patient factors, treatment considerations, medication issues, disease process, prescriber competencies and institutional support; (3) barriers: patient resistance, prescribing inertia, knowledge gaps, coordination issues, time constraints, cost and pharmaceutical influences. Doctors demonstrated a moderate understanding of deprescribing but faced several contextual challenges, highlighting the need for targeted education, institutional policies and deprescribing frameworks in LMICs.</p>\",\"PeriodicalId\":8733,\"journal\":{\"name\":\"Basic & Clinical Pharmacology & Toxicology\",\"volume\":\"137 5\",\"pages\":\"\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-10-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12497502/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Basic & Clinical Pharmacology & Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.70121\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic & Clinical Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.70121","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

随着可能不适当的药物在尼泊尔等低收入和中等收入国家(LMICs)日益普遍,开处方的作用变得越来越重要。然而,关于尼泊尔医生如何看待在他们的实践中处方的证据是缺乏的。采用结构化问卷对尼泊尔中部一家三级教学医院的115名医生进行了顺序解释性混合方法研究。李克特量表项目的定量数据进行了描述性分析,同时对开放式回答进行了主题分析。只有45名医生(39.1%)听说过“开处方”,77.8%的医生说自己在开处方。大多数医生(80%)理解每个处方背后的基本原理,94.3%的医生同意确保患者理解处方药。只有52.4%的人经常让患者参与开处方的决定,31.4%的人承认有时开了“太多的药”。定性分析确定了三个与减少处方相关的主题:(1)一般认识:减少处方被视为一个有计划的、系统的过程,以优化治疗,最大限度地减少多药,降低成本,提高安全性;(2)促成因素:患者因素、治疗考虑、用药问题、疾病进程、开处方者能力和机构支持;(3)障碍:患者阻力、处方惯性、知识空白、协调问题、时间限制、成本和药物影响。医生表现出对处方的适度理解,但面临着一些背景挑战,突出了中低收入国家需要有针对性的教育、制度政策和处方框架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Exploration of Perceptions of Deprescribing Practices Among Doctors in a Low- and Middle-Income Country: A Mixed-Methods Study

Exploration of Perceptions of Deprescribing Practices Among Doctors in a Low- and Middle-Income Country: A Mixed-Methods Study

With the increasing prevalence of potentially inappropriate medications in low- and middle-income countries (LMICs) like Nepal, the role of deprescribing is ever important. However, evidence on how Nepalese doctors perceive deprescribing in their practice is lacking. A sequential explanatory mixed-method study was conducted among 115 doctors at a tertiary-level teaching hospital in central Nepal using a structured questionnaire. Quantitative data from Likert-scale items were analysed descriptively, while thematically analysing open-ended responses. Only 45 doctors (39.1%) had heard of deprescribing, and 77.8% reported practising it. Most doctors (80%) understood the rationale behind each prescription, and 94.3% agreed on ensuring patient comprehension of prescribed medicines. Only 52.4% routinely involved patients in deprescribing decisions, and 31.4% acknowledged prescribing ‘too many drugs’ at times. Qualitative analysis identified three deprescribing-related themes: (1) general understanding: deprescribing viewed as a planned, systematic process to optimize treatment, minimize polypharmacy, reduce costs, and improve safety; (2) Enablers: patient factors, treatment considerations, medication issues, disease process, prescriber competencies and institutional support; (3) barriers: patient resistance, prescribing inertia, knowledge gaps, coordination issues, time constraints, cost and pharmaceutical influences. Doctors demonstrated a moderate understanding of deprescribing but faced several contextual challenges, highlighting the need for targeted education, institutional policies and deprescribing frameworks in LMICs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
6.50%
发文量
126
审稿时长
1 months
期刊介绍: Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信